
Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ — Alamar Biosciences, Inc. (“Alamar”), a leader in precision proteomics dedicated to advancing the…
Read More









